On Wednesday 21 October 2020 the British Pharmacological Society will offer a free webinar dedicated to The pharmacology of drugs for COVID-19.
In this webinar, sponsored by the British Journal of Pharmacology and the British Journal of Clinical Pharmacology, expert will present their research on pharmacological strategies for the treatment of COVID-19.
15:00-15:10: Opening Remarks, Professor Amrita Ahluwalia, British Journal of Pharmacology, UK
15:10-15:20: A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development, Dr Steve Alexander, University of Nottingham, UK
15:20-15:30: The hidden role of NLRP3 inflammasome in obesity-related COVID-19 exacerbations: lessons for drug repurposing, Dr Ilaria Bertocchi Università di Torino, Italy
15:30-15:40: A clinical pharmacology roadmap out of future pandemics, Professor Duncan Richards, University of Oxford, UK
15:40-15:50: Dosing will be a key success factor in repurposing antivirals for COVID‐19, Dr Patrick Smith, Certara, USA
15:50-16:00: Harnessing inflammation resolving‐based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID‐19?, Professor Mauro Teixeira, Universidade Federal de Minas Gerais, Brazil
16:00-16:30: Live Q&A, all speakers
Link to register: https://buff.ly/34bouig